Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
336
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
+9.93K
-
Total reported value, excl. options
-
$5.92B
-
Value change
-
+$12.1M
-
Put/Call ratio
-
8
-
Number of buys
-
152
-
Number of sells
-
-159
-
Price
-
$312.99
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2018
367 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q3 2018.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 336 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
.
Largest 10 shareholders include BlackRock Inc. (1.87M shares), Vanguard Group Inc (1.83M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.32M shares), ACADIAN ASSET MANAGEMENT LLC (704K shares), WELLS FARGO & COMPANY/MN (688K shares), AMERICAN CENTURY COMPANIES INC (688K shares), TimesSquare Capital Management, LLC (522K shares), STATE STREET CORP (510K shares), MILLENNIUM MANAGEMENT LLC (378K shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (347K shares).
This table shows the top 336 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.